Outsourced Pharma Capacity Update | July 2023

07.20.2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live presentation, watch ondemand to learn how Emergent is equipped to support the scale-up and CGMP manufacturing for your next clinical or commercial therapy.

OPCU Webinar - JUN2023 - Cover Image

Emergent CDMO

Drug Product Fill/Finish Webinars

02.13.2021

Emergent Enters Into a New CDMO Agreement with Providence Therapeutics to Provide Fill/Finish Drug Product Manufacturing

Emergent has entered into a new CDMO agreement with Providence Therapeutics to provide fill/finish drug product manufacturing...

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

07.06.2020

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate

Emergent will provide contract development and manufacturing services beginning in 2021 to produce drug substance at large...